HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Erythromycylamine

HCID 83952
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
26116-56-3
Standard SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](N)[C@H](C)[C@@H](O)[C@]1(C)O
InChIKey
XCLJRCAJSCMIND-JCTYMORFSA-N
Molecular formula
C37H70N2O12
Average molar mass
735 g/mol
Monoisotopic mass
734.49287567

Overview

(9S)-erythromycyclamine is a macrolide antibiotic that is erythromycin A in which the ketone group has been converted into the corresponding imine and then reduced to give the corresponding amino compound (the 9S diastereoisomer).

Names & identifiers

Preferred name
Erythromycylamine
IUPAC
(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
English name
(9S)-9-Amino-9-deoxoerythromycin
Molecular formula
C37H70N2O12
Molecular weight
734.96

Names & synonyms

Erythromycylamine26116-56-3(9S)-9-Amino-9-deoxoerythromycin9(S)-Erythromycylamine9-EpierythromycylamineBRN 4241492(9S)-9-amino-9-deoxyerythromycinYX9KV1OMA4erythromyclamine, (9S)-BRL-42852ERLY-024410RefChem:405596
Show more names
LY 024410BRL 42852ERErythromycilamine9-()-Eythromyeyamine9-(S)-AMINOERYTHROMYCIN
406-790-7(9S)-erythromycyclamineDirithromycin EP Impurity AEpierythromycyl-A-amineErythromycin, 9-amino-9-deoxo-, (9S)-MFCD00872156CHEMBL290242(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one

Database identifiers

CAS
26116-56-3

Properties

Computed structural properties

XLogP
3.5
Topological polar surface area
203 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
14
Rotatable bonds
7
Heavy atoms
51
Formal charge
0
Complexity
1,140

Experimental & physicochemical properties

LogP3.0

Physicochemical properties

Melting point
123 · 123-127°C
Boiling point
810.3 · 810.3±65.0 °C(Predicted)
Density
1.19 · 1.19±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility
15 mg/ml; · DMF: 15 mg/ml; DMSO: 15 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS (pH 7.2) (1:1): 0.5 mg/ml
form
A solid
pka
13.41 · 13.41±0.70(Predicted)
color
White to off-white
optical activity
Consistent with structure
InChIKey
XCLJRCAJSCMIND-FLSDEJNQNA-N
EWG's Food Scores
1 · 1
FDA UNII
9 KV1OMA4 · YX9KV1OMA4

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H318: Causes serious eye damage [Danger Serious eye damage/eye irritation]

P264+P265, P273, P280, P305+P354+P338, P317, P391, and P501 (click each P-code to see the statement)

Danger

H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

P264+P265, P273, P280, P305+P354+P338, P317, P391, and P501 (click each P-code to see the statement)

Hazard information

Regulatory InformationREACH registered substance: (9S)-9-amino-9-deoxyerythromycin (EC: 406-790-7)
Hazard Classes and Categories · 3 items

Eye Dam. 1 (100%)

Eye damage - category 1

Eye Dam. 1

Safety data

Toxicity
mouse,LD50,intraperitoneal,120mg/kg (120mg/kg),European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 13, Pg. 83, 1978.
risk_code
41-50/53
Signal word
Danger
Symbol(GHS)
GHS05,GHS09
hazard_code
Xi,N
safety_code
26-39-60-61
Hazard statements
H318-H410
REACH Registrations
Inactive
Precautionary statements
P280-P305+P351+P338-P310-P273-P391-P501

Chemistry & industry

Applications · 3 items

Uses(9S)-9-Amino-9-deoxoerythromycin is a semi-synthetic analogue of erythromycin prepared by reduction of erythromycin oxime. (9S)-9-Amino-9-deoxoerythromycin is a potent antibiotic, however the introduction of the amino- moiety increases the compound’s polarity and is disadvantageous for in vivo use. This limitation was overcome by the synthesis of dirithromycin, a Schiff base pro-drug that dissociates in vivo to erythromycylamine.

UsesErythromycylamine is a semi-synthetic analogue of erythromycin prepared by reduction of erythromycin oxime. Erythromycylamine is a potent antibiotic, however the introduction of the amino- moiety increases the compound’s polarity and is disadvantageous for in vivo use. This limitation was overcome by the synthesis of dirithromycin, a Schiff base pro-drug that dissociates in vivo to erythromycylamine.

Uses(9S)-9-Amino-9-deoxoerythromycin is a metabolite of Dirithromycin; an antibiotic

Additional notes

DefinitionChEBI: A macrolide antibiotic that is erythromycin A in which the ketone group has been converted to the corresponding imine and then reduced to give the corresponding amino compound (the 9S diastereoisomer).

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
PubChem CID
83952
DTXSID
DTXSID00180750
ChEMBL
CHEMBL1201397、CHEMBL290242
ChEBI
CHEBI:73708
UNII
YX9KV1OMA4
EC Number
406-790-7
Symbol(GHS)
5 · GHS05,GHS09
Signal word
Danger
Hazard statements
318 · H318-H410
Precautionary statements
280 · P280-P305+P351+P338-P310-P273-P391-P501
Hazard Codes
Xi,N
Risk Statements
41 · 41-50/53
Safety Statements
26 · 26-39-60-61
Toxicity
50 · mouse,LD50,intraperitoneal,120mg/kg (120mg/kg),European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 13, Pg. 83, 1978.
REACH Registrations
Inactive